Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin and Radiation Therapy for Melanoma
NCT00707161Phase 2Terminated
- Sponsor
- University of Utah
- Start
- Sep 2005
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in Malignant Melanoma (MM), sponsored by University of Utah. Started Sep 2005; status: terminated.
02
Drugs
cisplatin
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00707161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00707161.